The cost of treating advanced non-small cell lung cancer: estimates from the chinese experience.

<h4>Background</h4>Because of the potentially significant economic burden of healthcare costs associated with many diseases, it is critical that regulatory and medical insurance organisations collect and utilise data on the cost-effectiveness of care provision to make rational policy dec...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Xiaohui Zeng, Jonathan Karnon, Siying Wang, Bin Wu, Xiaomin Wan, Liubao Peng
Format: article
Langue:EN
Publié: Public Library of Science (PLoS) 2012
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/61b7172900c44d00bd6102368b0ea5af
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!